Core Viewpoint - The announcement from Kangzhong Medical indicates a successful inquiry transfer with a determined transfer price of 22.99 yuan per share, reflecting strong interest from institutional investors [1] Group 1: Inquiry Transfer Details - The inquiry transfer attracted bids from 12 institutional investors, including fund management companies, qualified foreign institutional investors, securities firms, and private fund managers [1] - The total number of shares effectively subscribed by participating institutional investors reached 6.002 million shares, resulting in an effective subscription multiple of 1.28 times [1] - The total number of shares intended for transfer has been fully subscribed, with the preliminary determination of 11 institutional investors as the transferees, aiming to acquire a total of 4.7 million shares [1]
康众医疗:询价转让定价22.99元/股